The HELZ2 Knockout HeLa Polyclonal Cells constitute a CRISPR/Cas9-mediated gene-disrupted polyclonal cell population derived from the HeLa host cell line, offering a robust loss-of-function model for studying HELZ2 biology. This product provides a heterogeneous knockout pool in which the HELZ2 gene is disrupted across a polyclonal cell population, enabling the study of nonsense-mediated mRNA decay without clonal artifacts. The cells are suitable for a range of molecular and cellular assays requiring ablation of HELZ2 function.
HeLa cells are an immortalized epithelial cell line isolated from a cervical adenocarcinoma, positive for human papillomavirus type 18 (HPV-18). These cells are widely used in cancer research due to their robust growth characteristics and relevance to HPV-associated malignancies. The HeLa background provides a well-characterized model for studying oncogenic pathways and host-virus interactions, particularly in the context of mRNA surveillance mechanisms.
HELZ2 encodes an RNA helicase that plays a critical role in the nonsense-mediated mRNA decay (NMD) pathway, a conserved mRNA surveillance mechanism that detects and degrades transcripts containing premature termination codons (PTCs). HELZ2 functions by recognizing PTC-containing mRNAs and interacting with the core NMD factors UPF1, SMG5, and SMG7 to facilitate transcript degradation. The UPF1-SMG5-SMG7 complex serves as the central effector complex, with HELZ2 contributing to the remodeling of RNA-protein structures required for decay. While upstream regulators of HELZ2 remain poorly defined, cellular stress pathways are thought to modulate its activity, linking NMD to broader cellular responses.
In HeLa cells, which harbor HPV-18 oncogenes, the NMD pathway may be influenced by viral proteins that manipulate host gene expression. Disruption of HELZ2 in this background allows researchers to dissect NMD functionality in a cancer-relevant setting, where aberrant mRNA surveillance can contribute to tumorigenesis through altered expression of tumor suppressor genes or oncogenes. This knockout model thus provides a valuable tool for investigating how RNA quality control pathways intersect with cancer biology.
Typical applications include biochemical analysis of HELZ2 protein levels by Western blotting, quantitative gene expression analysis via RT-qPCR, transcriptome-wide profiling through RNA-seq, and functional assessment of NMD activity using luciferase-based NMD reporter assays. Co-immunoprecipitation experiments can be employed to examine HELZ2 interactions with UPF1, SMG5, and SMG7. This polyclonal knockout cell population is an essential resource for researchers investigating NMD machinery, RNA quality control, and cancer biology. For further details or custom inquiries, please contact Ascent Research.
